CausalSentinel

Protein Dossier — PDK1 ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Ferritin 0.0607 0.0196 0.00195 Wald ratio 1 cis NA
Cancer code self-reported: prostate cancer 0.154 0.0501 0.00218 Wald ratio 1 cis NA
Mean cell haemoglobin 0.0567 0.0201 0.00484 Wald ratio 1 cis NA
Fractured bone site(s): Other bones 0.0472 0.0207 0.0223 Wald ratio 1 cis NA
Non-cancer illness code self-reported: enlarged prostate -0.0993 0.0471 0.0351 Wald ratio 1 cis NA
Diagnoses - main ICD10: D25 Leiomyoma of uterus -0.0993 0.0486 0.0413 Wald ratio 1 cis NA
Red blood cell count -0.00892 0.00437 0.0414 Wald ratio 1 cis NA
Forearm bone mineral density 0.0616 0.0327 0.0596 Wald ratio 1 cis NA
Eye problems or disorders: Glaucoma 0.0726 0.0388 0.0612 Wald ratio 1 cis NA
Knee osteoarthritis -0.102 0.0545 0.0616 Wald ratio 1 cis NA
Non-cancer illness code self-reported: pulmonary embolism (with or without) dvt 0.0934 0.0504 0.0638 Wald ratio 1 cis NA
Non-cancer illness code self-reported: high cholesterol 0.0242 0.0131 0.0656 Wald ratio 1 cis NA
…and 81 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-5227_60_3 PDK1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

7 association rows across 6 traits (3 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Height 8e-12 rs836624 2 GCST90245848 no MR -> candidate analysis
Insomnia 4e-8 rs836603 1 GCST90131901 no MR -> candidate analysis
Crohn’s disease 1e-6 rs151175749 1 GCST90446792 no MR -> candidate analysis
Gastric cancer 2e-6 rs12693006 1 GCST90455528 no MR -> candidate analysis
Erectile dysfunction in type 1 diabetes 2e-6 rs836589 1 GCST001572 no MR -> candidate analysis
Behenoyl sphingomyelin (d18:1/22:0) levels in elite athletes 6e-6 rs12693006 1 GCST90133880 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 488 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
prostate carcinoma 0.657 common-variant locus no MR -> candidate analysis
brain cancer 0.515 common-variant locus no MR -> candidate analysis
Crohn disease 0.498 common-variant locus no MR -> candidate analysis
liver disorder 0.484 common-variant locus no MR -> candidate analysis
prostate cancer 0.197 common-variant locus MR: beta=0.154, p=0.00218 (cis)
mental disorder 0.171 common-variant locus no MR -> candidate analysis

Of the 6 rows above, 5 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 2 known modulators (3-phosphoinositide-dependent protein kinase 1)
gnomAD constraint pLI=4.7e-10, LOEUF=0.94 — LoF-tolerant
GWAS Catalog 46 unique SNPs / 82 rows
ClinVar 100 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance